Estrogen-induced protection against experimental autoimmune encephalomyelitis is abrogated in the absence of B cells

European Journal of Immunology

Volumn 41, Issue 4, 2011, Pages 1165-1175

  Bodhankar, Sheetal ^a,b   Wang, Chunhe ^a   Vandenbark, Arthur A ^a,b   Offner, Halina ^a,b  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

EAE; Estrogen; MS; Regulatory B cells

Indexed keywords

CD1D ANTIGEN; CD5 ANTIGEN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; INTERLEUKIN 10; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PROGRAMMED DEATH 1 LIGAND 1;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL FUNCTION; CELL INFILTRATION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; T CELL DEPLETION; T LYMPHOCYTE; UPREGULATION;

ANIMALS; ANTIGENS, CD1D; ANTIGENS, CD5; ANTIGENS, CD80; B-LYMPHOCYTES; CELLS, CULTURED; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ESTRADIOL; ESTROGENS; FEMALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PEPTIDES; SPLEEN;

EID: 79953045436     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201040992     Document Type: Article

References (41)

1. Abramsky, O., Pregnancy and multiple sclerosis. Ann. Neurol. 1994. 36: S38-S41.
2. Confavreux, C., Hutchinson, M., Hours, M. M., Cortinovis-Tourniaire, P. and Moreau, T., Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N. Engl. J. Med. 1998. 339: 285-291.
3. Soldan, S. S., Alvarez Retuerto, A. I., Sicotte, N. L. and Voskuhl, R. R., Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol. J. Immunol. 2003. 171: 6267-6274.
4. Kuchroo, V. K., Martin, C. A., Greer, J. M., Ju, S. T., Sobel, R. A. and Dorf, M. E., Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J. Immunol. 1993. 151: 4371-4382.
5. Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y. H., Wang, Y. et al., A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 2005. 6: 1133-1141.
6. Matsushita, T., Yanaba, K., Bouaziz, J. D., Fujimoto, M. and Tedder, T. F., Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J. Clin. Invest. 2008. 118: 3420-3430.
7. + phenotype controls T cell-dependent inflammatory responses. Immunity 2008. 28: 639-650.
8. Bebo, B. F., Jr., Fyfe-Johnson, A., Adlard, K., Beam, A. G., Vandenbark, A. A. and Offner, H., Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains. J. Immunol. 2001. 166: 2080-2089.
9. Ito, A., Bebo, B. F., Jr., Matejuk, A., Zamora, A., Silverman, M., Fyfe-Johnson, A. and Offner, H., Estrogen treatment down-regulates TNF-alpha production and reduces the severity of experimental autoimmune encephalomyelitis in cytokine knockout mice. J. Immunol. 2001. 167: 542-552.
10. Levin, E. R., Cellular functions of plasma membrane estrogen receptors. Steroids 2002. 67: 471-475.
11. Polanczyk, M., Zamora, A., Subramanian, S., Matejuk, A., Hess, D. L., Blankenhorn, E. P., Teuscher, C. et al., The protective effect of 17beta-estradiol on experimental autoimmune encephalomyelitis is mediated through estrogen receptor-alpha. Am. J. Pathol. 2003. 163: 1599-1605.
12. Polanczyk, M. J., Jones, R. E., Subramanian, S., Afentoulis, M., Rich, C., Zakroczymski, M., Cooke, P. et al., T lymphocytes do not directly mediate the protective effect of estrogen on experimental autoimmune encephalomyelitis. Am. J. Pathol. 2004. 165: 2069-2077.
13. +regulatory T cell compartment. J. Immunol. 2004. 173: 2227-2230.
14. Cross, A. H., Trotter, J. L. and Lyons, J., B cells and antibodies in CNS demyelinating disease. J. Neuroimmunol. 2001. 112: 1-14.
15. Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D. and Anderton, S. M., B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 2002. 3: 944-950.
16. Wolf, S. D., Dittel, B. N., Hardardottir, F. and Janeway, C. A., Jr., Experimental autoimmune encephalomyelitis induction in genetically B-cell-deficient mice. J. Exp. Med. 1996. 184: 2271-2278.
17. Lyons, J. A., San, M., Happ, M. P. and Cross, A. H., B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide. Eur. J. Immunol. 1999. 29: 3432-3439.
18. Bettelli, E., Baeten, D., Jager, A., Sobel, R. A. and Kuchroo, V. K., Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice. J. Clin. Invest. 2006. 116: 2393-2402.
19. Matsushita, T., Fujimoto, M., Hasegawa, M., Komura, K., Takehara, K., Tedder, T. F. and Sato, S., Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response. Am. J. Pathol. 2006. 168: 812-821.
20. Omari, K. M., Lutz, S. E., Santambrogio, L., Lira, S. A. and Raine, C. S., Neuroprotection and remyelination after autoimmune demyelination in mice that inducibly overexpress CXCL1. Am. J. Pathol. 2009. 174: 164-176.
21. Bagaeva, L. V., Rao, P., Powers, J. M. and Segal, B. M., CXC chemokine ligand 13 plays a role in experimental autoimmune encephalomyelitis. J. Immunol. 2006. 176: 7676-7685.
22. Zamvil, S. S. and Steinman, L., The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 1990. 8: 579-621.
23. Offner, H., Neuroimmunoprotective effects of estrogen and derivatives in experimental autoimmune encephalomyelitis: therapeutic implications for multiple sclerosis. J. Neurosci. Res. 2004. 78: 603-624.
24. Polanczyk, M. J., Hopke, C., Vandenbark, A. A. and Offner, H., Estrogen-mediated immunomodulation involves reduced activation of effector T cells, potentiation of Treg cells, and enhanced expression of the PD-1 costimulatory pathway. J. Neurosci. Res. 2006. 84: 370-378.
25. + regulatory T cells implicates compensatory pathways including regulatory B cells. Immunology. 2011. 132: 340-347.
26. Polanczyk, M. J., Hopke, C., Vandenbark, A. A. and Offner, H., Treg suppressive activity involves estrogen-dependent expression of programmed death-1 (PD-1). Int. Immunol. 2007. 19: 337-343.
27. Wang, C., Li, Y., Proctor, T. M., Vandenbark, A. A. and Offner, H., Down-modulation of programmed death 1 alters regulatory T cells and promotes experimental autoimmune encephalomyelitis. J. Neurosci. Res. 2010. 88: 7-15.
28. Magliozzi, R., Howell, O., Vora, A., Serafini, B., Nicholas, R., Puopolo, M., Reynolds, R. and Aloisi, F., Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 2007. 130: 1089-1104.
29. Krumbholz, M., Theil, D., Cepok, S., Hemmer, B., Kivisakk, P., Ransohoff, R. M., Hofbauer, M. et al., Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain 2006. 129: 200-211.
30. Harp, C. T., Lovett-Racke, A. E., Racke, M. K., Frohman, E. M. and Monson, N. L., Impact of myelin-specific antigen presenting B cells on T cell activation in multiple sclerosis. Clin. Immunol. 2008. 128: 382-391.
31. Duddy, M., Niino, M., Adatia, F., Hebert, S., Freedman, M., Atkins, H., Kim, H. J. and Bar-Or, A., Distinct effector cytokine profiles of memory and naive human B-cell subsets and implication in multiple sclerosis. J. Immunol. 2007. 178: 6092-6099.
32. Kincade, P. W., Medina, K. L., Payne, K. J., Rossi, M. I., Tudor, K. S., Yamashita, Y. and Kouro, T., Early B-lymphocyte precursors and their regulation by sex steroids. Immunol. Rev. 2000. 175: 128-137.
33. Grimaldi, C. M., Cleary, J., Dagtas, A. S., Moussai, D. and Diamond, B., Estrogen alters thresholds for B-cell apoptosis and activation. J. Clin. Invest. 2002. 109: 1625-1633.
34. Thurmond, T. S., Murante, F. G., Staples, J. E., Silverstone, A. E., Korach, K. S. and Gasiewicz, T. A., Role of estrogen receptor alpha in hematopoietic stem cell development and B lymphocyte maturation in the male mouse. Endocrinology 2000. 141: 2309-2318.
35. Wang, C., Dehghani, B., Li, Y., Kaler, L. J., Vandenbark, A. A. and Offner, H., Oestrogen modulates experimental autoimmune encephalomyelitis and interleukin-17 production via programmed death 1. Immunology 2009. 126: 329-335.
36. Carter, L. L., Leach, M. W., Azoitei, M. L., Cui, J., Pelker, J. W., Jussif, J., Benoit, S. et al., PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 2007. 182: 124-134.
37. Matsushita, T., Horikawa, M., Iwata, Y. and Tedder, T. F., Regulatory B cells (b10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis. J. Immunol. 2010. 185: 2240-2252.
38. Hauser, S. L., Waubant, E., Arnold, D. L., Vollmer, T., Antel, J., Fox, R. J., Bar-Or, A. et al., B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N. Engl. J. Med. 2008. 358: 676-688.
39. Haas, K. M., Watanabe, R., Matsushita, T., Nakashima, H., Ishiura, N., Okochi, H., Fujimoto, M., et al. Protective and pathogenic roles for B cells during systemic autoimmunity in NZB/W F1 mice. J. Immunol. 2010. 184: 4789-4800.
40. Offner, H., Adlard, K., Zamora, A. and Vandenbark, A. A., Estrogen potentiates treatment with T-cell receptor protein of female mice with experimental encephalomyelitis. J. Clin. Invest. 2000. 105: 1465-1472.
41. Rabchevsky, A. G., Fugaccia, I., Sullivan, P. G. and Scheff, S. W., Cyclosporin A treatment following spinal cord injury to the rat: behavioral effects and stereological assessment of tissue sparing. J. Neurotrauma 2001. 18: 513-522.